Dyne Therapeutics, Inc. (DYN) NASDAQ

17.04

-0.42(-2.41%)

Updated at January 13 04:00PM

Currency In USD

Valuation

Market Cap2.22B
Enterprise Value1.81B
P/E Ratio-5.7
PEG Ratio-1.1
Price/Sales Ratio0
Price/Book Ratio3.49
Enterprise/Revenue0
Enterprise/EBITDA-4.34

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.49
Return On Equity-0.66

Income Statement

Revenue0
Revenue/Share0
Gross Profit-2.24M
EBITDA-315.18M
Net Income-317.42M
Diluted EPS-3.37

Balance Sheet

Total Cash791.89M
Total Cash/Share5.58
Total Debt21.32M
Total Debt/Equity0.03
Current Ratio13.47
Book Value Per Share4.88

Price History

52-Week Change13.6
52-Week High25
52-Week Low6.36
Moving Average 50 Days19.94
Moving Average 200 Days13.93

Statistics

Average Volume2.87M
Shares Outstanding142.84M
% Held by Institutions136.85

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A